DS9 Document EFTA00697382

From: To: "Jeffrey E." <[email protected]> Subject: Re: From wikipedia... Date: Mon, 19 Jun 2017 14:46:00 +0000 > Maybe so On Jun 19, 2017, at 1:09 AM, jeffrey E. [email protected]> wrote: Are the ears - Flowers. Wax coating small hairs On Mon, Jun 19, 2017 at 2:12 AM wrote: I went through this list of protein aggregation diseases or proteopathies ... or what I'm calling aggregopathies. It's not a problem with the protein, it's a problem be they aggregate. Anyway, I just did a basic search of all of the names and checked to see if there was evidence for change in intracellular PH with all...yup/not all are in neurons. Weird = this is what happens when you acidify the soil. Proteopathy Major aggregating protein Alzheimer's diseaserlq Amyloid [3 peptide (AR); Tau protein (see tauopathies) Cerebral [3-amyloid angiopathy1491 Amyloid [3 peptide (A(3) Retinal ganglion cell degeneration in glaucoma1501 Amyloid [3 peptide (A(3) Prion diseases (multiple)I511 Prion protein Parkinson% disease and other synucleinopathies (multiple)(521 a-Synuclein Tauopathies (multiple)153] Microtubule-associated protein tau (Tau protein) Frontotemporal lobar degeneration (FTLD) (Ubi+, Tau-)154I TDP-43 FTLD_FUS1541 Fused in sarcoma (RJS) protein Amyotrophic lateral sclerosis (ALS)1551561 Superoxide dismutase, TDP-43, FUS, C9ORF72, ubiquilin-2 (UBQLN2) Huntington's disease and other trinucleotide repeat disorders (multiple)15115e1 Proteins with tandem glutamine expansions Familial British dementia[491 ABri Familial Danish dementia[491 ADan Hereditary cerebral hemorrhage with amyloidosis (Icelandic) (HCHWA-I)1491 Cystatin C CADASIL1591 Notch3 Alexander diseaserq Glial fibrillary acidic protein (GFAP) Seipinopathiespii Seipin EFTA00697382 Familial amyloidotic neuropathy, Senile systemic amyloidosis 2 Transthyrefin16 1 Serpinopathies (multiple)1631 Serpins AL (light chain) amyloidosis (primary systemic amyloidosis ) Monoclonal immunoglobulin light chains1621 All (heavy chain) amyloidosis Immunoglobulin heavy chains[621 AA (secondary) amyloidosis Amyloid A protein[621 Type II diabetes[641 Islet amyloid polypeptide (IAPP; amylin) Aortic medial amyloidosis Medin (lactadherin)16~1 ApoAl amyloidosis Apolipoprotein Alt6~1 ApoAll amyloidosis Apolipoprotein Allt6~1 ApoAlV amyloidosis Apolipoprotein AIV1621 Familial amyloidosis of the Finnish type (FAF) Gelsolin[621 Lysozyme amyloidosis Lysozymet6~1 Fibrinogen amyloidosis Fibrinogen1621 Dialysis amyloidosis Beta-2 microglobulint6~1 Inclusion body myositis/myopathy[69 Amyloid f3 peptide (AB) Cataractsisq Crystallins Retinitis pigmentosa with rhodopsin mutations[671 rhodopsin Medullary thyroid carcinoma Calcitonin(621 Cardiac atrial amyloidosis Atrial natriuretic factort6~1 Pituitary prolactinoma Prolactint6~1 Hereditary lattice comeal dystrophy Keratoepithelin(621 Cutaneous lichen amyloidosis(681 Keratins Mallory bodies(691 Keratin intermediate filament proteins Corneal lactoferrin amyloidosis Lactoferrint6~1 Pulmonary alveolar proteinosis Surfactant protein C (SP-C)t6~1 Odontogenic (Pindborg) tumor amyloid Odontogenic ameloblast-associated protein16~1 Seminal vesicle amyloid Semenogelin 1164 Apolipoprotein C2 amyloidosis Apolipoprotein C2 (ApoC2)1621 Apolipoprotein C3 amyloidosis Apolipoprotein C3 (ApoC3)1621 Lect2 amyloidosis Leukocyte chemotactic factor-2 (Lect2)t6~1 Insulin amyloidosis Insulin(621 Galectin-7 amyloidosis (primary localized cutaneous amyloidosis) Galectin-7 (Gal7)(621 Corneodesmosin amyloidosis Corneodesmosinl6~1 Enfuvirtide amyloidosisrmi Enfuvirtidel6~1 Cystic Fibrosis cystic fibrosis transmembrane conductance regulator (CFTR) protein Sickle cell diseasern i Hemoglobin please note EFTA00697383 The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved EFTA00697384